Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Medicale (MCLE) Shares Outstanding (Diluted Average) (2021 - 2025)

Medicale's Shares Outstanding (Diluted Average) history spans 5 years, with the latest figure at $5.9 million for Q2 2025.

  • For Q2 2025, Shares Outstanding (Diluted Average) changed 0.0% year-over-year to $5.9 million; the TTM value through Jun 2025 reached $5.9 million, changed 0.0%, while the annual FY2024 figure was $5.9 million, 0.0% changed from the prior year.
  • Shares Outstanding (Diluted Average) reached $5.9 million in Q2 2025 per MCLE's latest filing, roughly flat from $5.9 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $5.9 million in Q4 2021 to a low of $3.6 million in Q3 2021.
  • Average Shares Outstanding (Diluted Average) over 5 years is $5.7 million, with a median of $5.9 million recorded in 2021.
  • The largest YoY upside for Shares Outstanding (Diluted Average) was 63.73% in 2022 against a maximum downside of 0.0% in 2022.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $5.9 million in 2021, then changed by 0.0% to $5.9 million in 2022, then changed by 0.0% to $5.9 million in 2023, then changed by 0.0% to $5.9 million in 2024, then changed by 0.0% to $5.9 million in 2025.
  • Per Business Quant, the three most recent readings for MCLE's Shares Outstanding (Diluted Average) are $5.9 million (Q2 2025), $5.9 million (Q1 2025), and $5.9 million (Q4 2024).